Studies reported to date have correlated HMGB1 upregulation with the onset and progression of melanoma, colon cancer, breast cancer, and pancreatic cancer, chiefly pointing towards the role of HMGB1 in augmenting neo-angiogenesis in cancerous tumor [103,104,105]. This evidence concerns the gene HMGB1 and breast carcinoma.